TickerHumSide-by-side comparison
Abbott Laboratories vs Becton, Dickinson and
As of Nov 11, 2026, P/E is 40.8x for Abbott Laboratories vs 64.2x for Becton, Dickinson and; P/S is 3.9x for Abbott Laboratories vs 2.6x for Becton, Dickinson and; revenue growth is 10.0% for Abbott Laboratories vs 18.5% for Becton, Dickinson and; operating margin is 13.8% for Abbott Laboratories vs 10.7% for Becton, Dickinson and.
What stands out
- Abbott Laboratories is cheaper on earnings: 40.8x P/E vs 64.2x for Becton, Dickinson and.
- Becton, Dickinson and's shares did better over the past year: +40.7% vs -14.8% for Abbott Laboratories.
Key metrics
| Metric | ABT | BDX |
|---|---|---|
| Price | $109.80 | $212.46 |
| Market cap | $190.17B | $57.87B |
| P/E | 40.8x (#1) | 64.2x (#2) |
| P/S | 3.9x (#2) | 2.6x (#1) |
| Revenue growth | 10.0% (#2) | 18.5% (#1) |
| Operating margin | 13.8% (#1) | 10.7% (#2) |
| Net margin | 9.7% (#1) | 4.2% (#2) |
| Debt / equity | 0.58 (#2) | 0.55 (#1) |
| 1-year return | -14.8% (#2) | +40.7% (#1) |
| Research score | 49/100 (#2) | 52/100 (#1) |
Higher is better for growth, margins, one-year return and overall score; lower is better for valuation and debt ratios. Ties share a rank and missing values are excluded.
Company research
- Abbott Laboratories (ABT) — Medical Devices
- Becton, Dickinson and Company (BDX) — Medical Instruments & Supplies